Sep 14, 2020 9:15am EDT DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study
Aug 11, 2020 4:05pm EDT DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
Aug 06, 2020 4:05pm EDT DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020
May 19, 2020 4:42pm EDT DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
May 13, 2020 4:41pm EDT DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
May 13, 2020 4:40pm EDT DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
May 07, 2020 4:30pm EDT DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
